These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 101714)

  • 21. New anti-HSV therapeutics target the helicase-primase complex.
    Crumpacker CS; Schaffer PA
    Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
    [No Abstract]   [Full Text] [Related]  

  • 22. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
    Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
    J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for herpes simplex virus infections.
    Erlich KS; Mills J
    West J Med; 1985 Nov; 143(5):648-55. PubMed ID: 3909643
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possibilities and limits of chemotherapy of diseases caused by herpes simplex and varicella-zoster virus].
    Wassilew SW
    Hautarzt; 1983 Jan; 34(1):1-5. PubMed ID: 6841073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of herpes simplex].
    Engst R
    Z Hautkr; 1988; 63 Suppl 4():76-8. PubMed ID: 3075384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the clinical and experimental chemotherapy of virus infections].
    Rohde B; Hellmig HP
    Z Haut Geschlechtskr; 1967 Mar; 42(6):185-200. PubMed ID: 5582565
    [No Abstract]   [Full Text] [Related]  

  • 27. [Virustatic substances in local treatment of herpetic dermatoses].
    Nasemann T; Braun-Falco O
    Ther Ggw; 1970 Feb; 109(2):222-36. PubMed ID: 5441694
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of varicella zoster and herpes simplex virus-induced diseases. 2: References for implementing and indications for virustatic therapy].
    Mahler V; Schuler G
    Hautarzt; 2001 Jun; 52(6):554-73. PubMed ID: 11428090
    [No Abstract]   [Full Text] [Related]  

  • 29. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An antiviral subtance extracted from Streptococcus faecalis.
    Hotta S; Kojima M; Fujisaki M; Uchida S; Kuroda H; Hamada C
    Nature; 1977 Aug; 268(5622):733-4. PubMed ID: 197425
    [No Abstract]   [Full Text] [Related]  

  • 31. Kethoxal for treatment of cutaneous herpes simplex.
    Underwood GE
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):235-9. PubMed ID: 5686520
    [No Abstract]   [Full Text] [Related]  

  • 32. New observations on the determination of bacterial lipid phosphorus.
    Toennies G; Das DN; Feng F
    Can J Microbiol; 1968 Apr; 14(4):484-5. PubMed ID: 4967221
    [No Abstract]   [Full Text] [Related]  

  • 33. Semimicro extraction of ubiquinone and menaquinone from bacteria.
    Krivánková L; Dadák V
    Methods Enzymol; 1980; 67():111-4. PubMed ID: 6767895
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on virus-inhibiting substances of bacterial origin. I. Introduction.
    Hotta S
    Kobe J Med Sci; 1978 Jun; 24(2):87-90. PubMed ID: 101715
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on virus-inhibiting substances of bacterial origin. II. Inhibition of animal virus plaque formation by culture filtrates of lactic acid bacteria.
    Uchida S; Fujisaki M; Kojima M; Hotta S; Hamada K
    Kobe J Med Sci; 1978 Jun; 24(2):91-8. PubMed ID: 101716
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
    Enright AM; Prober C
    Herpes; 2003 Aug; 10(2):32-7. PubMed ID: 14577952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on virus-inhibiting substances of bacterial origin. IV. Antiviral substances extractable from Streptococcus faecalis: its in vivo effect.
    Fujisaki M; Uchida S; Kojima M; Hotta S; Hamada C; Maeyama Y
    Kobe J Med Sci; 1978 Jun; 24(2):115-23. PubMed ID: 101714
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on virus-inhibiting substances of bacterial origin. III. Antiviral substance extractable from Streptococcus faecalis: its in vitro activities and some biological characteristics.
    Fujisaki M; Uchida S; Kojima M; Hotta S; Kuroda H; Watsuji K; Hamada K
    Kobe J Med Sci; 1978 Jun; 24(2):99-114. PubMed ID: 101717
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.